FOSB and diabetes mellitus: Here, we described chronic neuronal activity (i.e., FosB expression) in the spinal dorsal horn of segments L4–L5 and in the lateral part of PAG in our STZ diabetes model and found that PACAP treatment effectively prevented FosB activation in these centers.